logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Alison Pedley

merck & company usa
H指数:33
被引数:6,540

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors

3期试验评估V114的安全性，耐受性和免疫原性，15价肺炎球菌结合疫苗，6个月后23价肺炎球菌多糖疫苗，在18-49岁的高危成年人 (pneu-day): 基线风险因素的亚组分析

HUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
2023-03-024
OAAI
Hammitt, Laura L.; Quinn, Dean; Janczewska, Ewa; Pasquel, Francisco J.; Tytus, Richard; Reddy, K. Rajender; Abarca, Katia; Khaertynova, Ilsiyar M. M.; Dagan, Ron; Dawson, Rachel; McCauley, Jennifer; Shekar, Tulin; Fu, Wei; Pedley, Alison; Sterling, Tina; Tamms, Gretchen; Musey, Luwy; Buchwald, Ulrike K.
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

莫那普韦用于非住院患者的新型冠状病毒肺炎口服治疗

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2022-02-101.2K
OAAI
Bernal, A. Jayk; da Silva, M. M. Gomes; Musungaie, D. B.; Kovalchuk, E.; Gonzalez, A.; Delos Reyes, V; Martin-Quiros, A.; Caraco, Y.; Williams-Diaz, A.; Brown, M. L.; Du, J.; Pedley, A.; Assaid, C.; Strizki, J.; Grobler, J. A.; Shamsuddin, H. H.; Tipping, R.; Wan, H.; Paschke, A.; Butterton, J. R.; Johnson, M. G.; De Anda, C.
Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)

15价肺炎球菌结合疫苗V114在18-49岁有或没有肺炎球菌疾病危险因素的免疫能力成年人中的免疫原性，安全性和耐受性: 一项随机3期试验 (PNEU-DAY)

OPEN FORUM INFECTIOUS DISEASES
IF3.8
2021-12-1813
OAAI
Hammitt, Laura L.; Quinn, Dean; Janczewska, Ewa; Pasquel, Francisco J.; Tytus, Richard; Reddy, K. Rajender; Abarca, Katia; Khaertynova, Ilsiyar M.; Dagan, Ron; McCauley, Jennifer; Cheon, Kyeongmi; Pedley, Alison; Sterling, Tina; Tamms, Gretchen; Musey, Luwy; Buchwald, Ulrike K.
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

V114是一种15价肺炎球菌结合疫苗，在 ≥ 50岁健康成人中与流感疫苗同时接种的安全性、耐受性和免疫原性: 一项随机3期试验 (pneu-flu)

HUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
2021-11-0214
OAAI
Severance, Randall; Schwartz, Howard; Dagan, Ron; Connor, Laurie; Li, Jianing; Pedley, Alison; Hartzel, Jonathan; Sterling, Tina M.; Nolan, Katrina M.; Tamms, Gretchen M.; Musey, Luwy K.; Buchwald, Ulrike K.
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

健康老年人15价肺炎球菌结合疫苗 (PCV-15) 与PCV-13疫苗的安全性和免疫原性比较

HUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
2019-01-1688
OAAI
Stacey, Helen L.; Rosen, Jeffrey; Peterson, James T.; Williams-Diaz, Angela; Gakhar, Vanita; Sterling, Tina M.; Acosta, Camilo J.; Nolan, Katrina M.; Li, Jianing; Pedley, Alison; Benner, Patrice; Abeygunawardana, Chitrananda; Kosinski, Michael; Smith, William J.; Pujar, Hari; Musey, Luwy K.

研究方向

暂未获取到该数据
J
Joseph M. Massaro
H 指数:131论文数:591被引数:7.4万
C
Caroline S. Fox
H 指数:153论文数:889被引数:10.8万
U
Udo Hoffmann
H 指数:105论文数:848被引数:4.7万
J
Joanne M. Murabito
H 指数:102论文数:525被引数:5.2万
U
Udo Hoffmann
H 指数:44论文数:150被引数:1.1万
M
Michelle T. Long
H 指数:42论文数:212被引数:7,959
R
Ramachandran S. Vasan
H 指数:204论文数:1,882被引数:19.4万
E
Emelia J. Benjamin
H 指数:201论文数:1,368被引数:33.2万
L
Luwy Musey
H 指数:26论文数:76被引数:2,983
T
Tina M. Sterling
H 指数:14论文数:56被引数:682